Optiver Holding B.V. Amicus Therapeutics, Inc. Transaction History
Optiver Holding B.V.
- $6 Billion
- Q3 2025
A detailed history of Optiver Holding B.V. transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Optiver Holding B.V. holds 1,802 shares of FOLD stock, worth $16,794. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,802
Previous 1,767
1.98%
Holding current value
$16,794
Previous $10,000
40.0%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding FOLD
# of Institutions
306Shares Held
327MCall Options Held
396KPut Options Held
249K-
Vanguard Group Inc Valley Forge, PA29.5MShares$275 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA29.1MShares$271 Million0.03% of portfolio
-
Black Rock Inc. New York, NY24.4MShares$227 Million0.01% of portfolio
-
Avoro Capital Advisors LLC New York, NY18MShares$168 Million1.88% of portfolio
-
William Blair Investment Management, LLC Chicago, IL14.6MShares$136 Million0.24% of portfolio
About AMICUS THERAPEUTICS, INC.
- Ticker FOLD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 280,497,984
- Market Cap $2.61B
- Description
- Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...